CLINICAL_TRIALS
trial_result
· 2023-01-18
Clinical Trial Update: A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx [Phase 2]
Summary
Phase 2 trial assessing safety, tolerability and efficacy of IONIS-AGT-LRx in hypertension has completed; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2023-01-18